FBIO Earnings & Financial Statements
Fortress Biotech, Inc.
$1.90
-$0.05(-2.56%)
41
Overall
65
Value
18
Tech
42
Quality
Market Cap
$63.37M
Volume
376.10K
52W Range
$2.00 - $4.53
Target Price
$11.00
FBIO earnings and financial statements: Fortress Biotech, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
FBIO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $63.26M | $57.67M | $84.51M | $75.74M | $5.66M |
| Cost of revenue | $20.92M | $20.88M | $22.89M | $30.77M | $41.62M |
| Operating income | -$70.22M | -$110.38M | -$142.34M | -$206.43M | -$251.65M |
| EBITDA | -$25.53M | -$111.18M | -$127.21M | -$193.69M | -$146.17M |
| Net income | $6.82M | -$46.00M | -$60.64M | -$86.58M | -$64.70M |
| EPS (diluted) | $-0.07 | $-2.69 | $-8.47 | $-14.55 | $-30.30 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $185.55M | $144.22M | $167.53M | $294.16M | $396.50M |
| Total liabilities | $123.36M | $145.87M | $165.94M | $244.28M | $170.63M |
| Shareholders’ equity | $49.87M | $22.74M | $22.54M | $41.72M | $108.67M |
| Cash and equivalents | $79.38M | $57.26M | $80.93M | $178.27M | $305.74M |
| Long-term debt | $65.09M | $72.71M | $79.14M | $113.30M | $63.92M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$65.78M | -$80.19M | -$128.22M | -$179.40M | -$116.57M |
| Capital expenditure | $1.17M | -$15.00M | -$8.10M | -$3.06M | -$16.35M |
| Free cash flow | -$65.78M | -$95.19M | -$136.32M | -$182.46M | -$132.89M |
| Dividends paid | $664.0K | $4.71M | $8.77M | $8.78M | $8.78M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FBIO | $1.90 | -2.6% | 376.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |